▶ 調査レポート

世界の転移性脊髄腫瘍市場:市場規模・現状・予測

• 英文タイトル:Global Metastases Spinal Tumor Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の転移性脊髄腫瘍市場:市場規模・現状・予測 / Global Metastases Spinal Tumor Market Size, Status and Forecast 2019-2025 / QYR9N7549資料のイメージです。• レポートコード:QYR9N7549
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、転移性脊髄腫瘍のグローバル市場について調査・分析したレポートで、種類別(硬膜外、その他)、用途別(病院と診療所、外来手術センター、学術機関、研究センター、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・転移性脊髄腫瘍の世界市場規模
・主要企業別市場シェア
・転移性脊髄腫瘍の世界市場規模:種類別(硬膜外、その他)
・転移性脊髄腫瘍の世界市場規模:用途別(病院と診療所、外来手術センター、学術機関、研究センター、その他)
・転移性脊髄腫瘍のアメリカ市場規模(種類別、用途別)
・転移性脊髄腫瘍のヨーロッパ市場規模(種類別、用途別)
・転移性脊髄腫瘍の中国市場規模(種類別、用途別)
・転移性脊髄腫瘍の日本市場規模(種類別、用途別)
・転移性脊髄腫瘍の東南アジア市場規模(種類別、用途別)
・転移性脊髄腫瘍のインド市場規模(種類別、用途別)
・転移性脊髄腫瘍の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・転移性脊髄腫瘍の世界市場予測(2019年-2025年)
・転移性脊髄腫瘍の地域別市場予測(2019年-2025年)
...

A spine tumor is an abnormal growth of tissue found in and/or around the spinal column and/or spinal cord. More than 95% of all metastatic spinal tumors are found outside the dura (extradural) and within the vertebral body, and in more than half of the cases they are found on multiple levels of the spine.It is common for cancer cells to metastasize, or spread, to bones. Most commonly, cancer cells spread to the lung, the liver, and the bones, respectively, and most bone metastases occur in the spine. The most common way for cancer cells to reach the spine is via the blood stream, after which they enter the bone marrow and begin to multiply.
In 2018, the global Metastases Spinal Tumor market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metastases Spinal Tumor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metastases Spinal Tumor development in United States, Europe and China.

The key players covered in this study
Roche
Amgen
Novartis
Abbott
Beckman Coulter
Debiopharm Group
AbbVie
Bayer

Market segment by Type, the product can be split into
Extradural
Others

Market segment by Application, split into
Hospital And Clinics
Ambulatory Surgery Centers
Academic Institutes
Research Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metastases Spinal Tumor status, future forecast, growth opportunity, key market and key players.
To present the Metastases Spinal Tumor development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metastases Spinal Tumor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metastases Spinal Tumor Market Size Growth Rate by Type (2014-2025)
1.4.2 Extradural
1.4.3 Others
1.5 Market by Application
1.5.1 Global Metastases Spinal Tumor Market Share by Application (2014-2025)
1.5.2 Hospital And Clinics
1.5.3 Ambulatory Surgery Centers
1.5.4 Academic Institutes
1.5.5 Research Centers
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metastases Spinal Tumor Market Size
2.2 Metastases Spinal Tumor Growth Trends by Regions
2.2.1 Metastases Spinal Tumor Market Size by Regions (2014-2025)
2.2.2 Metastases Spinal Tumor Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Metastases Spinal Tumor Market Size by Manufacturers
3.1.1 Global Metastases Spinal Tumor Revenue by Manufacturers (2014-2019)
3.1.2 Global Metastases Spinal Tumor Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metastases Spinal Tumor Market Concentration Ratio (CR5 and HHI)
3.2 Metastases Spinal Tumor Key Players Head office and Area Served
3.3 Key Players Metastases Spinal Tumor Product/Solution/Service
3.4 Date of Enter into Metastases Spinal Tumor Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metastases Spinal Tumor Market Size by Type (2014-2019)
4.2 Global Metastases Spinal Tumor Market Size by Application (2014-2019)

5 United States
5.1 United States Metastases Spinal Tumor Market Size (2014-2019)
5.2 Metastases Spinal Tumor Key Players in United States
5.3 United States Metastases Spinal Tumor Market Size by Type
5.4 United States Metastases Spinal Tumor Market Size by Application

6 Europe
6.1 Europe Metastases Spinal Tumor Market Size (2014-2019)
6.2 Metastases Spinal Tumor Key Players in Europe
6.3 Europe Metastases Spinal Tumor Market Size by Type
6.4 Europe Metastases Spinal Tumor Market Size by Application

7 China
7.1 China Metastases Spinal Tumor Market Size (2014-2019)
7.2 Metastases Spinal Tumor Key Players in China
7.3 China Metastases Spinal Tumor Market Size by Type
7.4 China Metastases Spinal Tumor Market Size by Application

8 Japan
8.1 Japan Metastases Spinal Tumor Market Size (2014-2019)
8.2 Metastases Spinal Tumor Key Players in Japan
8.3 Japan Metastases Spinal Tumor Market Size by Type
8.4 Japan Metastases Spinal Tumor Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metastases Spinal Tumor Market Size (2014-2019)
9.2 Metastases Spinal Tumor Key Players in Southeast Asia
9.3 Southeast Asia Metastases Spinal Tumor Market Size by Type
9.4 Southeast Asia Metastases Spinal Tumor Market Size by Application

10 India
10.1 India Metastases Spinal Tumor Market Size (2014-2019)
10.2 Metastases Spinal Tumor Key Players in India
10.3 India Metastases Spinal Tumor Market Size by Type
10.4 India Metastases Spinal Tumor Market Size by Application

11 Central & South America
11.1 Central & South America Metastases Spinal Tumor Market Size (2014-2019)
11.2 Metastases Spinal Tumor Key Players in Central & South America
11.3 Central & South America Metastases Spinal Tumor Market Size by Type
11.4 Central & South America Metastases Spinal Tumor Market Size by Application

12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metastases Spinal Tumor Introduction
12.1.4 Roche Revenue in Metastases Spinal Tumor Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metastases Spinal Tumor Introduction
12.2.4 Amgen Revenue in Metastases Spinal Tumor Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metastases Spinal Tumor Introduction
12.3.4 Novartis Revenue in Metastases Spinal Tumor Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metastases Spinal Tumor Introduction
12.4.4 Abbott Revenue in Metastases Spinal Tumor Business (2014-2019)
12.4.5 Abbott Recent Development
12.5 Beckman Coulter
12.5.1 Beckman Coulter Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metastases Spinal Tumor Introduction
12.5.4 Beckman Coulter Revenue in Metastases Spinal Tumor Business (2014-2019)
12.5.5 Beckman Coulter Recent Development
12.6 Debiopharm Group
12.6.1 Debiopharm Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metastases Spinal Tumor Introduction
12.6.4 Debiopharm Group Revenue in Metastases Spinal Tumor Business (2014-2019)
12.6.5 Debiopharm Group Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metastases Spinal Tumor Introduction
12.7.4 AbbVie Revenue in Metastases Spinal Tumor Business (2014-2019)
12.7.5 AbbVie Recent Development
12.8 Bayer
12.8.1 Bayer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metastases Spinal Tumor Introduction
12.8.4 Bayer Revenue in Metastases Spinal Tumor Business (2014-2019)
12.8.5 Bayer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Metastases Spinal Tumor Key Market Segments
Table Key Players Metastases Spinal Tumor Covered
Table Global Metastases Spinal Tumor Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metastases Spinal Tumor Market Size Market Share by Type 2014-2025
Figure Extradural Figures
Table Key Players of Extradural
Figure Others Figures
Table Key Players of Others
Table Global Metastases Spinal Tumor Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital And Clinics Case Studies
Figure Ambulatory Surgery Centers Case Studies
Figure Academic Institutes Case Studies
Figure Research Centers Case Studies
Figure Others Case Studies
Figure Metastases Spinal Tumor Report Years Considered
Table Global Metastases Spinal Tumor Market Size 2014-2025 (Million US$)
Figure Global Metastases Spinal Tumor Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metastases Spinal Tumor Market Size by Regions 2014-2025 (Million US$)
Table Global Metastases Spinal Tumor Market Size by Regions 2014-2019 (Million US$)
Table Global Metastases Spinal Tumor Market Share by Regions 2014-2019
Figure Global Metastases Spinal Tumor Market Share by Regions 2014-2019
Figure Global Metastases Spinal Tumor Market Share by Regions 2019
Table Market Top Trends
Table Global Metastases Spinal Tumor Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metastases Spinal Tumor Market Share by Manufacturers (2014-2019)
Figure Global Metastases Spinal Tumor Market Share by Manufacturers in 2018
Table Global Metastases Spinal Tumor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metastases Spinal Tumor Product/Solution/Service
Table Date of Enter into Metastases Spinal Tumor Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metastases Spinal Tumor Market Size by Type (2014-2019) (Million US$)
Table Global Metastases Spinal Tumor Market Size Share by Type (2014-2019)
Figure Global Metastases Spinal Tumor Market Size Market Share by Type (2014-2019)
Table Global Metastases Spinal Tumor Market Size by Application (2014-2019) (Million US$)
Table Global Metastases Spinal Tumor Market Size Share by Application (2014-2019)
Figure Global Metastases Spinal Tumor Market Size Market Share by Application (2014-2019)
Figure Global Metastases Spinal Tumor Revenue Market Share by Application in 2018
Figure United States Metastases Spinal Tumor Market Size 2014-2019 (Million US$)
Table United States Key Players Metastases Spinal Tumor Revenue (2018-2019) (Million US$)
Table United States Key Players Metastases Spinal Tumor Market Share (2018-2019)
Table United States Metastases Spinal Tumor Market Size by Type (2014-2019) (Million US$)
Table United States Metastases Spinal Tumor Market Share by Type (2014-2019)
Table United States Metastases Spinal Tumor Market Size by Application (2014-2019) (Million US$)
Table United States Metastases Spinal Tumor Market Share by Application (2014-2019)
Figure Europe Metastases Spinal Tumor Market Size 2014-2019 (Million US$)
Table Europe Key Players Metastases Spinal Tumor Revenue (2018-2019) (Million US$)
Table Europe Key Players Metastases Spinal Tumor Market Share (2018-2019)
Table Europe Metastases Spinal Tumor Market Size by Type (2014-2019) (Million US$)
Table Europe Metastases Spinal Tumor Market Share by Type (2014-2019)
Table Europe Metastases Spinal Tumor Market Size by Application (2014-2019) (Million US$)
Table Europe Metastases Spinal Tumor Market Share by Application (2014-2019)
Figure China Metastases Spinal Tumor Market Size 2014-2019 (Million US$)
Table China Key Players Metastases Spinal Tumor Revenue (2018-2019) (Million US$)
Table China Key Players Metastases Spinal Tumor Market Share (2018-2019)
Table China Metastases Spinal Tumor Market Size by Type (2014-20189) (Million US$)
Table China Metastases Spinal Tumor Market Share by Type (2014-2019)
Table China Metastases Spinal Tumor Market Size by Application (2014-2019) (Million US$)
Table China Metastases Spinal Tumor Market Share by Application (2014-2019)
Figure Japan Metastases Spinal Tumor Market Size 2014-2019 (Million US$)
Table Japan Key Players Metastases Spinal Tumor Revenue (2018-2019) (Million US$)
Table Japan Key Players Metastases Spinal Tumor Market Share (2018-2019)
Table Japan Metastases Spinal Tumor Market Size by Type (2014-2019) (Million US$)
Table Japan Metastases Spinal Tumor Market Share by Type (2014-2019)
Table Japan Metastases Spinal Tumor Market Size by Application (2014-2019) (Million US$)
Table Japan Metastases Spinal Tumor Market Share by Application (2014-2019)
Figure Southeast Asia Metastases Spinal Tumor Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metastases Spinal Tumor Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metastases Spinal Tumor Market Share (2018-2019)
Table Southeast Asia Metastases Spinal Tumor Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metastases Spinal Tumor Market Share by Type (2014-2019)
Table Southeast Asia Metastases Spinal Tumor Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metastases Spinal Tumor Market Share by Application (2014-2019)
Figure India Metastases Spinal Tumor Market Size 2014-2019 (Million US$)
Table India Key Players Metastases Spinal Tumor Revenue (2018-2019) (Million US$)
Table India Key Players Metastases Spinal Tumor Market Share (2018-2019)
Table India Metastases Spinal Tumor Market Size by Type (2014-2019) (Million US$)
Table India Metastases Spinal Tumor Market Share by Type (2014-2019)
Table India Metastases Spinal Tumor Market Size by Application (2014-2019) (Million US$)
Table India Metastases Spinal Tumor Market Share by Application (2014-2019)
Figure Central & South America Metastases Spinal Tumor Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metastases Spinal Tumor Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metastases Spinal Tumor Market Share (2018-2019)
Table Central & South America Metastases Spinal Tumor Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metastases Spinal Tumor Market Share by Type (2014-2019)
Table Central & South America Metastases Spinal Tumor Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metastases Spinal Tumor Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Metastases Spinal Tumor Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Metastases Spinal Tumor Business (2014-2019)
Table Roche Recent Development
Table Amgen Company Details
Table Amgen Revenue in Metastases Spinal Tumor Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Metastases Spinal Tumor Business (2014-2019)
Table Amgen Recent Development
Table Novartis Company Details
Table Novartis Revenue in Metastases Spinal Tumor Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Metastases Spinal Tumor Business (2014-2019)
Table Novartis Recent Development
Table Abbott Company Details
Table Abbott Revenue in Metastases Spinal Tumor Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Metastases Spinal Tumor Business (2014-2019)
Table Abbott Recent Development
Table Beckman Coulter Company Details
Table Beckman Coulter Revenue in Metastases Spinal Tumor Business (2014-2019)(Million US$)
Figure Beckman Coulter Revenue Growth Rate in Metastases Spinal Tumor Business (2014-2019)
Table Beckman Coulter Recent Development
Table Debiopharm Group Company Details
Table Debiopharm Group Revenue in Metastases Spinal Tumor Business (2014-2019)(Million US$)
Figure Debiopharm Group Revenue Growth Rate in Metastases Spinal Tumor Business (2014-2019)
Table Debiopharm Group Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Metastases Spinal Tumor Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Metastases Spinal Tumor Business (2014-2019)
Table AbbVie Recent Development
Table Bayer Company Details
Table Bayer Revenue in Metastases Spinal Tumor Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Metastases Spinal Tumor Business (2014-2019)
Table Bayer Recent Development
Table Global Metastases Spinal Tumor Market Size by Regions (Million US$) 2019-2025
Figure Global Metastases Spinal Tumor Market Size Share by Regions (2019-2025)
Figure Global Metastases Spinal Tumor Market Size Share by Regions in 2025
Figure United States Metastases Spinal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metastases Spinal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure China Metastases Spinal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metastases Spinal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metastases Spinal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure India Metastases Spinal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metastases Spinal Tumor Market Size Forecast (2019-2025)(Million USD)
Table Global Metastases Spinal Tumor Market Size by Product (2019-2025) (Million US$)
Figure Global Metastases Spinal Tumor Market Size by Product (2019-2025)
Figure Global Metastases Spinal Tumor Market Size by Product in 2025
Table Global Metastases Spinal Tumor Market Size by Application (2019-2025) (Million US$)
Figure Global Metastases Spinal Tumor Market Size by Application (2019-2025)
Figure Global Metastases Spinal Tumor Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources